Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma

被引:0
作者
Hideki Goto
Shinichi Makita
Koji Kato
Kota Tokushige
Taizo Fujita
Koichi Akashi
Koji Izutsu
Takanori Teshima
机构
[1] Hokkaido University Faculty of Medicine,Department of Hematology, Graduate School of Medicine
[2] National Cancer Center Hospital,Department of Hematology
[3] Kyushu University Graduate School of Medical Sciences,Department of Medicine and Biosystemic Science
[4] Novartis Pharma K.K.,undefined
来源
International Journal of Clinical Oncology | 2020年 / 25卷
关键词
Tisagenlecleucel; CAR T-cell therapy; Diffuse large B-cell lymphoma; JULIET;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1736 / 1743
页数:7
相关论文
共 50 条
  • [21] Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial
    Fukuhara, Noriko
    Kato, Koji
    Goto, Hideki
    Takeshi, Tajima
    Kawaguchi, Mayu
    Tokushige, Kota
    Akashi, Koichi
    Teshima, Takanori
    Harigae, Hideo
    Schuster, Stephen J.
    Thieblemont, Catherine
    Dreyling, Martin
    Fowler, Nathan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (02) : 251 - 259
  • [22] Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial
    Noriko Fukuhara
    Koji Kato
    Hideki Goto
    Tajima Takeshi
    Mayu Kawaguchi
    Kota Tokushige
    Koichi Akashi
    Takanori Teshima
    Hideo Harigae
    Stephen J. Schuster
    Catherine Thieblemont
    Martin Dreyling
    Nathan Fowler
    International Journal of Hematology, 2023, 117 : 251 - 259
  • [23] Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: New Approved Options
    Garcia-Sancho, Alejandro Martin
    Cabero, Almudena
    Gutierrez, Norma C.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [24] Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients
    Bachanova, Veronika
    Westin, Jason
    Tam, Constantine
    Borchmann, Peter
    Jaeger, Ulrich
    McGuirk, Joseph
    Holte, Harald
    Waller, Edmund
    Jaglowski, Samantha
    Bishop, Michael
    Andreadis, Charalambos
    Foley, Ronan S.
    Fleury, Isabelle
    Teshima, Takanori
    Mielke, Stephan
    Salles, Gilles
    Ho, P. Joy
    Izutsu, Koji
    Maziarz, Richard
    Van Besien, Koen
    Kersten, Marie Jose
    Wagner-Johnston, Nina
    Kato, Koji
    Corradini, Paolo
    Han, Xia
    Agoulnik, Sergei
    Chu, Jufen
    Eldjerou, Lamis
    Pacaud, Lida
    Schuster, Stephen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S251 - S252
  • [25] Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma
    Tsutsue, Saaya
    Makita, Shinichi
    Yi, Jingbo
    Crawford, Bruce
    FUTURE ONCOLOGY, 2021, 17 (33) : 4511 - 4525
  • [26] The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma
    Armatys, A.
    Wieczorkiewicz-Kabut, A.
    Panz-Klapuch, M.
    Koclega, A.
    Kopinska, A. J.
    Kata, D.
    Wozniczka, K.
    Helbig, G.
    NEOPLASMA, 2020, 67 (06) : 1431 - 1436
  • [27] Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain
    Bastos-Oreiro, Mariana
    de las Heras, Ana
    Presa, Maria
    Casado, Miguel A.
    Pardo, Carlos
    Martin-Escudero, Victoria
    Sureda, Anna
    CANCERS, 2022, 14 (03)
  • [28] Loncastuximab Tesirine in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Juarez-Salcedo, Luis Miguel
    Nimkar, Santosh
    Corazon, Ana Maria
    Dalia, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [29] ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphoma
    Alderuccio, Juan Pablo
    Sharman, Jeff P.
    BLOOD REVIEWS, 2022, 56